Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.8K Buy
+6,771
New +$19.3K ﹤0.01% 826
2022
Q2
Sell
-2,500
Closed -$8K 822
2022
Q1
$8K Buy
+2,500
New +$6.98K ﹤0.01% 552

Other funds holding ABEV

McIlrath & Eck's ABEV Position: Q1 2026 in Review

McIlrath & Eck opened a new position in Ambev (ABEV) in Q1 2026: 6,771 shares worth $19.8K. The stake represents ﹤0.01% of the portfolio and ranks #826 among its holdings. This is a return to the name: McIlrath & Eck previously reported a position in ABEV as recently as Q1 2022.

McIlrath & Eck first reported a position in ABEV in Q1 2022 and has held it in 2 quarters since. 403 funds tracked by Wall St. Rank hold ABEV as of Q1 2026.

  • McIlrath & Eck held 6,771 shares of Ambev worth $19.8K as of Q1 2026.
  • Ambev was a new McIlrath & Eck position in Q1 2026.
  • Ambev made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #826 holding.
  • McIlrath & Eck first reported a position in Ambev in Q1 2022 and has held it in 2 quarters since.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.